PMID- 29525545 OWN - NLM STAT- MEDLINE DCOM- 20180816 LR - 20190307 IS - 1873-5800 (Electronic) IS - 0968-0160 (Print) IS - 0968-0160 (Linking) VI - 25 IP - 2 DP - 2018 Mar TI - Time between anterior cruciate ligament injury and reconstruction and cartilage metabolism six-months following reconstruction. PG - 296-305 LID - S0968-0160(18)30030-9 [pii] LID - 10.1016/j.knee.2018.01.009 [doi] AB - BACKGROUND: To determine the association between time from injury to ACL reconstruction (Time(Injury-ACLR)) and biochemical markers of cartilage metabolism and inflammation six months following ACL reconstruction (ACLR). METHODS: Individuals with a unilateral ACL injury were enrolled at initial presentation in the orthopedic clinic; blood was collected six months following ACLR. Enzyme-linked immunosorbent assays were used to analyze the ratio of serum concentrations of type-II collagen breakdown (C2C) to synthesis (CPII), plasma matrix metalloproteinase-3 (MMP-3), interleukin-6 (IL-6), and serum aggrecan neoepitope (ARGS). We used separate linear regressions to assess associations between biochemical markers and Time(Injury-ACLR). RESULTS: Twenty-two participants (50% females, mean [SD], age 21.9 [4.5] years old; BMI 23.8 [2.6] kg/m(2)) completed the study. Time(Injury-ACLR) ranged from nine to 67days (31.0 [14.4days]). Greater Time(Injury-ACLR) predicted greater serum C2C:CPII ratios six months following ACLR (C2C:CPII=0.15 [0.02], R(2)=0.213, P=0.030). Males (R(2)=0.733, P=0.001) but not females (R(2)=0.030, P=0.609) demonstrated a significant association between greater C2C:CPII and Time(Injury-ACLR) at the six-month follow-up exam. Time(Injury-ACLR) did not associate with IL-6, MMP-3, or ARGS at six months. CONCLUSIONS: Greater time between injury and ACL reconstruction was associated with greater serum C2C:CPII six months following ACLR in males but not females, and IL-6, MMP-3, and ARGS levels were not associated with Time(Injury-ACLR) in males or females. The time between ACL injury and ACLR may affect collagen metabolism in males and should be further investigated in a larger study along with other patient-relevant outcomes. CI - Copyright (c) 2018 Elsevier B.V. All rights reserved. FAU - Davis, Hope C AU - Davis HC AD - Human Movement Science Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address: davishc@live.unc.edu. FAU - Spang, Jeffery T AU - Spang JT AD - Department of Orthopaedics, School of Medicine, University of North Carolina at Chapel Hill, NC, United States. FAU - Loeser, Richard F AU - Loeser RF AD - Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, United States. FAU - Larsson, Staffan AU - Larsson S AD - Lund University, Department of Clinical Sciences, Orthopaedics, Lund, Sweden. FAU - Ulici, Veronica AU - Ulici V AD - Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, United States. FAU - Troy Blackburn, J AU - Troy Blackburn J AD - Human Movement Science Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. FAU - Creighton, R Alexander AU - Creighton RA AD - Department of Orthopaedics, School of Medicine, University of North Carolina at Chapel Hill, NC, United States. FAU - Kamath, Ganesh M AU - Kamath GM AD - Department of Orthopaedics, School of Medicine, University of North Carolina at Chapel Hill, NC, United States. FAU - Jordan, Joanne M AU - Jordan JM AD - Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, United States. FAU - Marshall, Stephen W AU - Marshall SW AD - Injury Prevention Research Center, University of North Carolina at Chapel Hill, NC, United States. FAU - Pietrosimone, Brian AU - Pietrosimone B AD - Human Movement Science Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. LA - eng GR - R03 AR066840/AR/NIAMS NIH HHS/United States PT - Journal Article DEP - 20180307 PL - Netherlands TA - Knee JT - The Knee JID - 9430798 RN - 0 (Aggrecans) RN - 0 (Collagen Type II) RN - 0 (Interleukin-6) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Aggrecans/blood MH - Anterior Cruciate Ligament Injuries/*surgery MH - Cartilage, Articular/*metabolism MH - Chondrogenesis MH - Cohort Studies MH - Collagen Type II/blood MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Follow-Up Studies MH - Humans MH - Interleukin-6/blood MH - Linear Models MH - Male MH - Matrix Metalloproteinase 3/blood MH - Time-to-Treatment MH - Young Adult PMC - PMC5886724 MID - NIHMS949251 OTO - NOTNLM OT - ACLR OT - Biomarkers OT - C-propeptide of type II procollagen OT - C2C OT - CPII OT - Type-II collagen cleavage product COIS- Conflicts of Interest We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. EDAT- 2018/03/12 06:00 MHDA- 2018/08/17 06:00 PMCR- 2019/03/07 CRDT- 2018/03/12 06:00 PHST- 2017/10/25 00:00 [received] PHST- 2018/01/02 00:00 [revised] PHST- 2018/01/28 00:00 [accepted] PHST- 2018/03/12 06:00 [pubmed] PHST- 2018/08/17 06:00 [medline] PHST- 2018/03/12 06:00 [entrez] PHST- 2019/03/07 00:00 [pmc-release] AID - S0968-0160(18)30030-9 [pii] AID - 10.1016/j.knee.2018.01.009 [doi] PST - ppublish SO - Knee. 2018 Mar;25(2):296-305. doi: 10.1016/j.knee.2018.01.009. Epub 2018 Mar 7.